cbdMD, Inc. (YCBD)
0.488
-0.02
(-4.11%)
USD |
NYAM |
Aug 24, 16:00
cbdMD Net Income (Quarterly) : -1.127M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.127M |
| March 31, 2026 | -0.798M |
| December 31, 2025 | -0.2831M |
| September 30, 2025 | -0.68M |
| June 30, 2025 | -0.8953M |
| March 31, 2025 | -0.4808M |
| December 31, 2024 | 0.0151M |
| September 30, 2024 | -0.1528M |
| June 30, 2024 | 0.4597M |
| March 31, 2024 | -3.011M |
| December 31, 2023 | -0.9965M |
| September 30, 2023 | -15.87M |
| June 30, 2023 | -1.770M |
| March 31, 2023 | -1.337M |
| December 31, 2022 | -3.956M |
| September 30, 2022 | -14.63M |
| June 30, 2022 | -31.63M |
| March 31, 2022 | -4.657M |
| Date | Value |
|---|---|
| December 31, 2021 | -19.16M |
| September 30, 2021 | -3.026M |
| June 30, 2021 | 1.537M |
| March 31, 2021 | -12.51M |
| December 31, 2020 | -9.396M |
| September 30, 2020 | -6.259M |
| June 30, 2020 | -8.945M |
| March 31, 2020 | 14.88M |
| December 31, 2019 | 12.97M |
| September 30, 2019 | 17.81M |
| June 30, 2019 | -26.93M |
| March 31, 2019 | -31.85M |
| December 31, 2018 | -0.9209M |
| September 30, 2018 | -0.8806M |
| June 30, 2018 | 0.5653M |
| March 31, 2018 | 1.643M |
| December 31, 2017 | -1.265M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Tilray Brands, Inc. | -37.93M |
| Organogenesis Holdings, Inc. | -96.27M |
| Guardian Pharmacy Services, Inc. | 22.12M |
| Nektar Therapeutics | -40.62M |
| Elite Pharmaceuticals, Inc. | 5.911M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 5.554M |
| Total Expenses (Quarterly) | 6.681M |
| EPS Diluted (Quarterly) | -0.1129 |
| Enterprise Value | 5.522M |
| Gross Profit Margin (Quarterly) | 50.03% |
| Profit Margin (Quarterly) | -20.30% |
| Earnings Yield | -63.34% |
| Normalized Earnings Yield | -63.34 |